Annals of Oncology

News:

How long will we be able to afford increasing costs of healthcare? Or are they truly increasing?
Ann Oncol 12: 1027.
[PDF] [Request Permissions]

Generics or original agents? But which originals?
Ann Oncol 12: 1027.
[PDF] [Request Permissions]

The risks of natural remedies
Ann Oncol 12: 1027.
[PDF] [Request Permissions]

The Peto brothers strike again: On smoking and obesity
Ann Oncol 12: 1027.
[PDF] [Request Permissions]

Oxigene needs some oxygen
Ann Oncol 12: 1028.
[PDF] [Request Permissions]

Bones to chew for the stock market?
Ann Oncol 12: 1028.
[PDF] [Request Permissions]

Talis pater, talis filia
Ann Oncol 12: 1028.
[PDF] [Request Permissions]

A historical victory for Europe?
Ann Oncol 12: 1028.
[PDF] [Request Permissions]

Resistance to STI-571
Ann Oncol 12: 1029.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 12: 1029-1031.
[PDF] [Request Permissions]

Book reviews:

M. Starobinski and B. Chapuis

Book review
Ann Oncol 12: 1032.
[PDF] [Request Permissions]

V. Cerundolo

Book review
Ann Oncol 12: 1182.
[PDF] [Request Permissions]

Editorials:

J. G. McVie

Are European cancer patients getting a fair deal?
Ann Oncol 12: 1033-1035.
[PDF] [Request Permissions]

R. Stahel, G. Purkalne, J. Herrstedt, S. Jelic, B. Fevers, O. Kloke, H. Mellstedt, H. Pavlidis, and L. Jost

ESMO Minimum Clinical Recommendations - the beginning of a process
Ann Oncol 12: 1037-1038.
[PDF] [Request Permissions]

Reviews:

B. Glimelius

Chemoradiotherapy for rectal cancer - is there an optimal combination?
Ann Oncol 12: 1039-1045.
[Abstract] [PDF] [Request Permissions]

Special articles:

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer
Ann Oncol 12: 1047-1048.
[PDF] [Request Permissions]

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
Ann Oncol 12: 1049-1050.
[PDF] [Request Permissions]

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)
Ann Oncol 12: 1051-1052.
[PDF] [Request Permissions]

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer
Ann Oncol 12: 1053-1054.
[PDF] [Request Permissions]

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer
Ann Oncol 12: 1055.
[PDF] [Request Permissions]

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
Ann Oncol 12: 1057-1058.
[PDF] [Request Permissions]

ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
Ann Oncol 12: 1059-1060.
[PDF] [Request Permissions]

Original articles:

J. L. Marti, P. Bueso, J. I. Mayordomo, M. D. Isla, A. Saenz, P. Escudero, L. Murillo, E. Filipovich, R. Andress, and A. Tres

Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines
Ann Oncol 12: 1061-1065.
[Abstract] [PDF] [Request Permissions]

L. Gianni, P. Dombernowsky, G. Sledge, M. Martin, D. Amadori, S. G. Arbuck, P. Ravdin, M. Brown, M. Messina, D. Tuck, C. Weil, and B. Winograd

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer
Ann Oncol 12: 1067-1073.
[Abstract] [PDF] [Request Permissions]

J. S. Vaidya, M. Baum, J. S. Tobias, D. P. D'Souza, S. V. Naidu, S. Morgan, K. J. Harte, A. P. Sliski, and E. Thomson

Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer
Ann Oncol 12: 1075-1080.
[Abstract] [PDF] [Request Permissions]

A. Di Leo, D. Larsimont, D. Gabcberg, T. Jarvinen, M. Beauduin, A. Vindevoghel, J. Michel, Ch. Focan, F. Ries, Ph. Gobert, M.-T. Closon-Dejardin, S. Dolci, G. Rouas, M. Paesmans, J.-P. Lobelle, J. Isola, and M. J. Piccart

HER-2 and topo-isomerase II as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
Ann Oncol 12: 1081-1089.
[Abstract] [PDF] [Request Permissions]

S. Pergolizzi, N. Settineri, A. Santacaterina, P. Spadaro, R. Maisano, N. Caristi, V. Adamo, C. De Renzis, M. Mesiti, and S. Cascinu

Ipsilateral supraclavicular lymph nodes metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy
Ann Oncol 12: 1091-1095.
[Abstract] [PDF] [Request Permissions]

M. Venturini, A. Michelotti, P. Papaldo, L. Del Mastro, M. Bergaglio, R. Lionetto, G. Lunardi, C. Sguotti, L. Frevola, S. Donati, R. Rosso, and F. Cognetti

Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
Ann Oncol 12: 1097-1106.
[Abstract] [PDF] [Request Permissions]

H. J. M. Jacobs, J. A. A. M. van Dijck, E. M. H. A. de Kleijn, L. A. L. M. Kiemeney, and A. L. M. Verbeek

Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: A simulation study
Ann Oncol 12: 1107-1113.
[Abstract] [PDF] [Request Permissions]

A. du Bois, H. J. Lück, J. Pfisterer, W. Schroeder, J. U. Blohmer, R. Kimmig, V. Moebus, and J. Quaas

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer—a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group
Ann Oncol 12: 1115-1120.
[Abstract] [PDF] [Request Permissions]

Y. Saijo, G. Sato, K. Usui, M. Sato, M. Sagawa, T. Kondo, Y. Minami, and T. Nukiwa

Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma
Ann Oncol 12: 1121-1125.
[Abstract] [PDF] [Request Permissions]

O. Merimsky, A. Staroselsky, M. Inbar, Y. Schwartz, N. Wigler, A. Mann, S. Marmor, and J. Greif

Correlation between c-erbB-4 receptor expression and response to gemcitabine—cisplatin chemotherapy in non-small-cell lung cancer
Ann Oncol 12: 1127-1131.
[Abstract] [PDF] [Request Permissions]

Y. Yamada, K. Shirao, A. Ohtsu, N. Boku, I. Hyodo, H. Saitoh, Y. Miyata, and T. Taguchi

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
Ann Oncol 12: 1133-1137.
[Abstract] [PDF] [Request Permissions]

R. K. Ramanathan, A. Cnaan, R. G. Hahn, P. P. Carbone, and D. G. Haller

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
Ann Oncol 12: 1139-1143.
[Abstract] [PDF] [Request Permissions]

S. Ferrari, F. Bertoni, M. Mercuri, P. Picci, S. Giacomini, A. Longhi, and G. Bacci

Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
Ann Oncol 12: 1145-1150.
[Abstract] [PDF] [Request Permissions]

O. Rick, J. Beyer, N. Schwella, H. Schubart, J. Schleicher, and W. Siegert

Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor
Ann Oncol 12: 1151-1155.
[Abstract] [PDF] [Request Permissions]

M. Casanova, A. Ferrari, L. Gandola, E. Orlandi, F. Spreafico, M. Terenziani, P. Navarria, R. Luksch, M. Massimino, G. Cefalo, F. Lombardi, and F. Fossati-Bellani

Undifferentiated nasopharyngeal carcinoma in children and adolescents: Comparison between staging systems
Ann Oncol 12: 1157-1162.
[Abstract] [PDF] [Request Permissions]

A. Ferrari, G. Bisogno, M. Casanova, C. Meazza, G. Cecchetto, M. A. Mancini, I. Zanetti, R. Alaggio, V. Ninfo, and M. Carli

Childhood leiomyosarcoma: A report from the Soft Tissue Sarcoma Italian Cooperative Group
Ann Oncol 12: 1163-1168.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

E. M. Kirchner, M. Ebsen, J. Kirchner, D. Theegarten, and R. Voigtmann

Transformation of Hodgkin's disease to high-grade B-cell lymphoma: Remission after Rituximab monotherapy
Ann Oncol 12: 1169-1171.
[Abstract] [PDF] [Request Permissions]

M. Fakih, D. Schiff, R. Erlich, and T. F. Logan

Intramedullary spinal cord metastasis (ISCM) in renal cell carcinoma: A series of six cases
Ann Oncol 12: 1173-1177.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

L. Gianni, I. Panzini, D. Tassinari, A. M. Mianulli, F. Desiderio, and A. Ravaioli

Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer
Ann Oncol 12: 1179-1180.
[PDF] [Request Permissions]

I. Floriani, T. Dell'Anna, E. Mari, and V. Torri

The above letter was referred to the authors, who respond as follows:
Ann Oncol 12: 1180.
[PDF] [Request Permissions]

A. Sulkes and S. M. Stemmer

Doxorubicin-based chemotherapy in the elderly
Ann Oncol 12: 1180-1181.
[PDF] [Request Permissions]

N. K. Ibrahim

The above letter was referred to the authors, who respond as follows:
Ann Oncol 12: 1181.
[PDF] [Request Permissions]

Advertisements in this issue:

Aventis Pharmaceuticals
Ann Oncol 12: 1182.
[PDF] [Request Permissions]

European School of Oncology
Ann Oncol 12: 1183.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 12: 1184.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 12: 1185.
[PDF] [Request Permissions]

Kluwer Academic Publishers
Ann Oncol 12: 1186-1188.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.